Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients

Documenti analoghi

• Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
  di: Jessica Hedvat, et al.
  Pubblicazione: (2024)
• Chromomycosis in solid organ transplant recipients
  di: Isadora Zago Miotto, et al.
  Pubblicazione: (2024)
• Safety of anidulafungin in solid organ transplant recipients
  di: Aguado, J.M., et al.
  Pubblicazione: (2012)
• Genitourinary malignancies in kidney transplant recipients
  di: Masayoshi Okumi, et al.
  Pubblicazione: (2024)
• Use of biologics for psoriasis in solid organ transplant recipients
  di: Marta Costa Blasco, et al.
  Pubblicazione: (2024)